Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription Articles published in Radiology Retrieve available abstracts of 139 articles: HTML format

Single Articles

September 2026
1. AVRITSCHER R, Kim E, Chew V, Abou-Alfa GK, et al
   Convergence of Local and Systemic Therapies: A Comprehensive Society of Interventional Oncology Framework for (90)Y Radioembolization with Immunotherapy in HCC.
   Radiology. 2026;320:e251415.
   PubMed     Abstract available
   
   
   
2. LUO S, Wei X, Lu X, Wang Z, et al
   Histotripsy for Hepatocellular Carcinoma: From Bench to Bedside.
   Radiology. 2026;320:e254050.
   PubMed     Abstract available
   
   
   August 2026
3. WU X, Li J, Deng R, Xu X, et al
   Photon-counting CT Extracellular Volume Fraction for Liver Fibrosis Assessment: Validation against MR Elastography and Histopathology.
   Radiology. 2026;320:e253979.
   PubMed     Abstract available
   
   
   
4. YOO JS, Tak KY, Cho HS, Han JW, et al
   Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma.
   Radiology. 2026;320:e253280.
   PubMed     Abstract available
   
   
   
5. DEYIRMENDJIAN C, Tang A
   Hepatic Arterial Infusion Chemotherapy as Second-line Therapy in Advanced Hepatocellular Carcinoma: An Early Career Perspective.
   Radiology. 2026;320:e262083.
   PubMed    
   
   
   July 2026
6. JEON SK, Joo I, Kang HJ, Kim JH, et al
   Noncontrast Abbreviated MRI for Post-TACE Treatment Response Monitoring of Hepatocellular Carcinoma Based on Ancillary Features from LI-RADS.
   Radiology. 2026;320:e252803.
   PubMed     Abstract available
   
   
   
7. PARAMESWARAN M, Baikpour M, Hunt DT, Orlowski M, et al
   Best Practice: Implementation of Liver US Shear-Wave Elastography in Clinical Practice.
   Radiology. 2026;320:e252544.
   PubMed     Abstract available
   
   
   
8. LEE L, Lee J, Hao F, Lee EW, et al
   Robotic-assisted (90)Y Transarterial Radioembolization for Treatment of Hepatocellular Carcinoma: Initial Experience.
   Radiology. 2026;320:e253870.
   PubMed    
   
   
   
9. KIM J, Kim JH, Ko E, Kim JY, et al
   Endovascular Treatment of Intrahepatic Hepatic Artery Pseudoaneurysms: Safety and Efficacy According to Embolization Strategies.
   Radiology. 2026;320:e252859.
   PubMed     Abstract available
   
   
   June 2026
10. SHIN J, Yoo J, Gu K, Baek SY, et al
    Evaluating Accuracy of LI-RADS Nonradiation Treatment Response Algorithm v2024 and Ancillary Features at Hepatobiliary MRI versus CT.
    Radiology. 2026;319:e253143.
    PubMed     Abstract available
    
    
    
11. HEO S, Jung YJ, Choi ES, Kim S, et al
    Diagnostic Accuracy of Extracellular versus Hepatobiliary Contrast-enhanced MRI in LI-RADS Nonradiation Treatment Response Algorithm Version 2024.
    Radiology. 2026;319:e253854.
    PubMed     Abstract available
    
    
    
12. LI J, Pang C, Li H, Liu G, et al
    Sequencing Ablation and Systemic Therapy in Colorectal Liver Oligometastases: An Upfront versus Delayed Approach Nationwide Analysis.
    Radiology. 2026;319:e251003.
    PubMed     Abstract available
    
    
    May 2026
13. BERMAN ZT, De la Garza-Ramos C, Montazeri SA, Malone CD, et al
    Consortium on Bridging Radiation Segmentectomy (COBRAS): A Multicenter Study of Complete Pathologic Necrosis in Hepatocellular Carcinoma.
    Radiology. 2026;319:e251923.
    PubMed     Abstract available
    
    
    
14. BRUNSING RL, Syed AB, Hargreaves BA, Ennis DB, et al
    Diffusion-weighted Imaging of the Liver: Primed for New Business.
    Radiology. 2026;319:e250157.
    PubMed     Abstract available
    
    
    
15. WANG TC, Wei N, Bao Y, Li JX, et al
    CT Radiomics-based Machine Learning to Identify Intratumoral Fibrosis and Underlying Angiogenesis in Hepatocellular Carcinoma.
    Radiology. 2026;319:e250736.
    PubMed     Abstract available
    
    
    
16. MITTELSTEIN DR, Khurana A, Vodkin I, Vavinskaya V, et al
    Interobserver Agreement in Contrast-enhanced US for Hepatic Nodules in Patients with Fontan-associated Liver Disease.
    Radiology. 2026;319:e252622.
    PubMed     Abstract available
    
    
    April 2026
17. MENG F, Teng Y
    Abernethy Malformation Type I with Multiple Hepatic FNH/NRH.
    Radiology. 2026;319:e252981.
    PubMed    
    
    
    March 2026
18. CHOI ES, Koo B, Kim S, Song IH, et al
    MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller.
    Radiology. 2026;318:e252611.
    PubMed     Abstract available
    
    
    
19. LI Y, Lu S, Mao S, Li Q, et al
    Contrast-Enhanced US Using Perfluorobutane for Diagnosing Small HCC in High-Risk Patients: Comparison with MRI LI-RADS Version 2018.
    Radiology. 2026;318:e252271.
    PubMed     Abstract available
    
    
    
20. KUHNEL C, Schmidt TN, Freesmeyer M, Schricke M, et al
    Transarterial Radioembolization: Medical Staff Dosimetry for (90)Y-Resin, (90)Y-Glass, and (166)Ho-PLLA Microspheres.
    Radiology. 2026;318:e251822.
    PubMed     Abstract available
    
    
    
21. DOPPELT G, Occean BV, Fabbro-Peray P, Haefliger L, et al
    The Safety Standards for Liver Percutaneous Thermal Ablation: A Meta-Analysis of Adverse Events over 15 Years.
    Radiology. 2026;318:e251517.
    PubMed     Abstract available
    
    
    
22. DIMOPOULOS MP, Sotirchos VS, Vakiani E, Sigel C, et al
    Optimizing Colorectal Liver Metastasis Ablation through Metabolic Imaging, Margin Assessment, and Biopsy (The OPTABLATE Prospective Trial).
    Radiology. 2026;318:e250864.
    PubMed     Abstract available
    
    
    
23. CENTNER CS, Choi R, Georgiades CS, Yarchoan M, et al
    Thermal and Nonthermal Liver Ablation: Mechanistic Foundations, Clinical Implementation, Immunologic Trial Design, and Artificial Intelligence.
    Radiology. 2026;318:e250263.
    PubMed     Abstract available
    
    
    
24. CHO SH, Jung YJ, Hong SB, Choi SJ, et al
    Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma.
    Radiology. 2026;318:e252892.
    PubMed     Abstract available
    
    
    February 2026
25. QI BN, Zhao XY, Lv WJ, Shan S, et al
    Nodular Transformation-driven Circulatory Remodeling in Biliary Atresia-induced Pediatric Biliary Cirrhosis: A Three-dimensional Phase-Contrast CT Rendering.
    Radiology. 2026;318:e252332.
    PubMed     Abstract available
    
    
    
26. LEWIS S, Wildman-Tobriner B, Cuevas J, Calle S, et al
    Quality of Gadoxetate-enhanced MRI versus US during Hepatocellular Carcinoma Screening in Participants with Cirrhosis.
    Radiology. 2026;318:e251497.
    PubMed     Abstract available
    
    
    
27. KIM TH, Harding JJ, Chernyak V, Mendiratta-Lala M, et al
    How I Do It: Systemic Therapies for Primary Liver Cancers.
    Radiology. 2026;318:e251371.
    PubMed     Abstract available
    
    
    January 2026
28. GEORGIADES C
    Intrahepatic Cholangiocarcinoma: Local-Regional Therapies Join the Fight.
    Radiology. 2026;318:e253806.
    PubMed    
    
    
    
29. CHEN S, Qi H, Shen L, Lin L, et al
    Noninvasive Profiling for PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2026;318:e252521.
    PubMed    
    
    
    
30. PANG C, Li J, An C, Wang Z, et al
    Survival Outcomes of Microwave Ablation Compared with Repeat Liver Resection in the Treatment of Recurrent Intrahepatic Cholangiocarcinoma.
    Radiology. 2026;318:e243254.
    PubMed     Abstract available
    
    
    
31. CHENG MQ, Hu HT, Wu SH, Huang H, et al
    Prospective Multicenter Evaluation of Hepatocellular Carcinoma Surveillance under American Association for the Study of Liver Diseases Version 2023 Guidance.
    Radiology. 2026;318:e252252.
    PubMed     Abstract available
    
    
    
32. DAGGUMATI L, Stark L, Booth AL, Fraum TJ, et al
    Case 344: Hepatic Epithelioid Hemangioendothelioma.
    Radiology. 2026;318:e251815.
    PubMed     Abstract available
    
    
    
33. MATTEINI F, Vilgrain V
    Isolated Hepatic Mucormycosis in Acute Lymphoblastic Leukemia.
    Radiology. 2026;318:e252306.
    PubMed    
    
    
    December 2025
34. ZHU L, Jiang B, Fei X, Xu Y, et al
    Contrast-enhanced US Evaluation of Residual Hepatocellular Carcinoma Following Lenvatinib Combined with Anti-PD-1 Antibody Downstaging Therapy.
    Radiology. 2025;317:e251698.
    PubMed     Abstract available
    
    
    
35. XIAO Z, Liu X
    Hepatocellular Carcinoma Presenting as Bile Duct Tumor Thrombus without Obvious Intrahepatic Mass.
    Radiology. 2025;317:e251418.
    PubMed    
    
    
    November 2025
36. YU SCH, Chan L, Lee KF, Cho CCM, et al
    Ethiodized Oil-based Transarterial Chemoembolization for Hepatocellular Carcinoma: Randomized Clinical Trial of Anhydrous Cisplatin Suspension versus Cisplatin Emulsion.
    Radiology. 2025;317:e242982.
    PubMed     Abstract available
    
    
    
37. PARK R, Choi ES, Byun JH, Won HJ, et al
    Diagnostic Value of Precontrast Low Attenuation as a LI-RADS CT Ancillary Feature for Hepatocellular Carcinoma.
    Radiology. 2025;317:e251598.
    PubMed     Abstract available
    
    
    October 2025
38. DENG M, Li Z, Sun L, Wang H, et al
    Liver MRI-derived Proton Density Fat Fraction Predicts Diabetes Risk in Patients with Obesity: A Dose-Response Study.
    Radiology. 2025;317:e250026.
    PubMed     Abstract available
    
    
    
39. FOWLKES JB
    Microbubbles, Ultrasound, and Radiation: Finding the Treatment Synergy for Hepatocellular Carcinoma.
    Radiology. 2025;317:e252815.
    PubMed    
    
    
    September 2025
40. WESSNER CE, Forsberg F, Lyshchik A, O'Kane P, et al
    Microbubble-based Radiosensitization of Hepatocellular Carcinoma: Evaluation of Safety and Efficacy in a Phase II Randomized Trial.
    Radiology. 2025;316:e250083.
    PubMed     Abstract available
    
    
    August 2025
41. CANNELLA R
    MRI Quantitative Features: A Bridge to Hepatocellular Carcinoma Tumor Profiling.
    Radiology. 2025;316:e252216.
    PubMed     Abstract available
    
    
    
42. MATUSCHEWSKI NJ, Sobirey R, Revzin M, Zeevi T, et al
    Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma.
    Radiology. 2025;316:e242750.
    PubMed     Abstract available
    
    
    
43. XIA H, Min Y, Wang Y, Gao S, et al
    Multiparametric MRI Evaluation of Liver Fat and Iron after Glucagon-like Peptide-1 Receptor and Glucagon Receptor Dual-Agonist Treatment in a High-Fat Diet-induced Mouse Model.
    Radiology. 2025;316:e243780.
    PubMed     Abstract available
    
    
    July 2025
44. ABEDRABBO N, Lam ET, McInnes MDF, Dawit H, et al
    Impact of LI-RADS CT and MRI Ancillary Features on Diagnostic Performance: An Individual Participant Data Meta-Analysis.
    Radiology. 2025;316:e242278.
    PubMed     Abstract available
    
    
    
45. LEWANDOWSKI RJ, Serhal M, Padia SA, Kim E, et al
    The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy.
    Radiology. 2025;316:e240333.
    PubMed     Abstract available
    
    
    
46. HUANG TY, Li ZY, Tian J, Xie XJ, et al
    Metabolic Dysfunction-Associated Steatotic Liver Disease at Quantitative US: International Prospective Study.
    Radiology. 2025;316:e242564.
    PubMed     Abstract available
    
    
    
47. ZHANG W, Shen G
    Hepatic Langerhans Cell Histiocytosis Revealed at FAPI PET/CT.
    Radiology. 2025;316:e243458.
    PubMed    
    
    
    
48. REA B, Blakeborough A
    Case 339: Hepatobiliary Contrast Agent Uptake in an Adrenal Metastasis from Hepatocellular Carcinoma.
    Radiology. 2025;316:e242718.
    PubMed     Abstract available
    
    
    June 2025
49. ADAMO RG, van der Pol CB, Alabousi M, Lam E, et al
    Diagnostic Performance of CT/MRI LI-RADS Version 2018 Major Feature Combinations: Individual Participant Data Meta-Analysis.
    Radiology. 2025;315:e243450.
    PubMed     Abstract available
    
    
    May 2025
50. LIU H, Fan W, Li H, Qiao L, et al
    Idarubicin versus Epirubicin in Transarterial Chemoembolization for Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: An Open-label, Randomized, Phase IV Trial.
    Radiology. 2025;315:e242315.
    PubMed     Abstract available
    
    
    April 2025
51. WU H, Zhu Z, Li J, Qiu C, et al
    Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression.
    Radiology. 2025;315:e242349.
    PubMed     Abstract available
    
    
    
52. QIU C
    US Markers for Differentiating Hepatic Inflammation in Chronic Liver Disease: Still a Long Way to Go.
    Radiology. 2025;315:e242559.
    PubMed    
    
    
    
53. GUO X, Zhou Y
    Agenesis of the Intrahepatic Inferior Vena Cava with Pulmonary Venous Fistula.
    Radiology. 2025;315:e242069.
    PubMed    
    
    
    March 2025
54. LEE S, Yoon JK, Shin J, Shin H, et al
    US Liver Imaging Reporting and Data System Version 2017: A Systematic Review and Meta-Analysis.
    Radiology. 2025;314:e240450.
    PubMed     Abstract available
    
    
    
55. DELL T, Mesropyan N, Layer Y, Tischler V, et al
    Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study.
    Radiology. 2025;314:e241677.
    PubMed     Abstract available
    
    
    
56. REA B, Blakeborough A
    Case 339.
    Radiology. 2025;314:e242717.
    PubMed     Abstract available
    
    
    
57. AN J, Park R, Kim E, Na SK, et al
    LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C.
    Radiology. 2025;314:e241856.
    PubMed     Abstract available
    
    
    
58. SCHOLLNAST H
    Imaging-based Hepatocellular Carcinoma Diagnosis: An Extension of LI-RADS to Patients with Noncirrhotic Hepatitis C.
    Radiology. 2025;314:e250627.
    PubMed    
    
    
    February 2025
59. ZHANG YJ, Chen J, Zhou Z, Hu D, et al
    Transarterial Chemoembolization with Radiofrequency Ablation versus Surgical Resection for Small Late-Recurrence Hepatocellular Carcinoma.
    Radiology. 2025;314:e241096.
    PubMed     Abstract available
    
    
    
60. ZHANG K, He K, Zhang L, Li WC, et al
    Gadoxetic Acid-enhanced MRI Scoring Model to Predict Pathologic Features of Hepatocellular Carcinoma.
    Radiology. 2025;314:e233229.
    PubMed     Abstract available
    
    
    
61. RONOT M
    Advancing Care: Managing Small Late-Recurrence Hepatocellular Carcinoma with Image-guided Therapy.
    Radiology. 2025;314:e243768.
    PubMed    
    
    
    
62. BITAR R, Salem R, Finn R, Greten TF, et al
    Erratum for: Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2025;314:e259004.
    PubMed    
    
    
    January 2025
63. WILDMAN-TOBRINER B, Felice N, Kalisz KR, Allen BC, et al
    Photon-Counting CT Effects on Sensitivity for Liver Lesion Detection: A Reader Study Using Virtual Imaging.
    Radiology. 2025;314:e241568.
    PubMed     Abstract available
    
    
    
64. LYSHCHIK A, Kuon Yeng Escalante C, Siu Xiao T, Piscaglia F, et al
    Contrast-enhanced US of High-Risk Indeterminate Focal Liver Observations Categorized as LR-4 or LR-M at CT/MRI.
    Radiology. 2025;314:e240916.
    PubMed     Abstract available
    
    
    
65. LI W, Lv J, Li H, Song L, et al
    Quantification of Vascular Remodeling and Sinusoidal Capillarization to Assess Liver Fibrosis with Photoacoustic Imaging.
    Radiology. 2025;314:e241275.
    PubMed     Abstract available
    
    
    December 2024
66. KAMAYA A, Fetzer DT, Seow JH, Burrowes DP, et al
    LI-RADS US Surveillance Version 2024 for Surveillance of Hepatocellular Carcinoma: An Update to the American College of Radiology US LI-RADS.
    Radiology. 2024;313:e240169.
    PubMed     Abstract available
    
    
    
67. JANG HJ, Choi SH, Wee S, Choi SJ, et al
    CT- and MRI-based Factors Associated with Rapid Growth in Early-Stage Hepatocellular Carcinoma.
    Radiology. 2024;313:e240961.
    PubMed     Abstract available
    
    
    November 2024
68. HAGHSHOMAR M, Antonacci D, Smith AD, Thaker S, et al
    Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis.
    Radiology. 2024;313:e241171.
    PubMed     Abstract available
    
    
    
69. JIANG H, Cannella R, Wu Z, Beaufrere A, et al
    Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.
    Radiology. 2024;313:e233471.
    PubMed     Abstract available
    
    
    
70. HARMATH C
    Hepatocellular Carcinoma: The Meaning of Intratumoral Fat Patterns in Different Patient Populations.
    Radiology. 2024;313:e242740.
    PubMed    
    
    
    
71. LAI B, Zhong J
    Hepatic Langerhans Cell Histiocytosis.
    Radiology. 2024;313:e241037.
    PubMed    
    
    
    
72. ASLAM A, Chernyak V, Miller FH, Bashir M, et al
    CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.
    Radiology. 2024;313:e232408.
    PubMed     Abstract available
    
    
    
73. BITAR R, Salem R, Finn R, Greten TF, et al
    Interventional Oncology Meets Immuno-oncology: Combination Therapies for Hepatocellular Carcinoma.
    Radiology. 2024;313:e232875.
    PubMed     Abstract available
    
    
    October 2024
74. RIEDEL C, Hoffmann M, Ismahil M, Lenz A, et al
    Four-dimensional Flow MRI-based Computational Fluid Dynamics Simulation for Noninvasive Portosystemic Pressure Gradient Assessment in Patients with Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt.
    Radiology. 2024;313:e232989.
    PubMed     Abstract available
    
    
    
75. MATOS C, Metens T
    Liver Fibrosis: Diving into Microstructure with Diffusion-weighted Imaging.
    Radiology. 2024;313:e242548.
    PubMed    
    
    
    
76. ZHANG L, Long X, Chen L, Han X, et al
    Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI.
    Radiology. 2024;313:e240343.
    PubMed     Abstract available
    
    
    
77. CAO J, Mroueh N, Mercaldo N, Lennartz S, et al
    Detectability of Hypoattenuating Liver Lesions with Deep Learning CT Reconstruction: A Phantom and Patient Study.
    Radiology. 2024;313:e232749.
    PubMed     Abstract available
    
    
    
78. MOTOSUGI U, Watanabe H
    Navigating Hemodynamic Insights: A Promising Future with Four-dimensional Flow MRI and Computational Fluid Dynamics in Transjugular Intrahepatic Portosystemic Shunt Management.
    Radiology. 2024;313:e241857.
    PubMed    
    
    
    
79. FERRAIOLI G, Roccarina D, Barr RG
    Intersystem and Interoperator Agreement of US Attenuation Coefficient for Quantifying Liver Steatosis.
    Radiology. 2024;313:e240162.
    PubMed     Abstract available
    
    
    September 2024
80. MENDIRATTA-LALA M, Wiggermann P, Pech M, Serres-Creixams X, et al
    The #HOPE4LIVER Single-Arm Pivotal Trial for Histotripsy of Primary and Metastatic Liver Tumors.
    Radiology. 2024;312:e233051.
    PubMed     Abstract available
    
    
    
81. PIERCE TT, Ozturk A, Sherlock SP, Moura Cunha G, et al
    Reproducibility and Repeatability of US Shear-Wave and Transient Elastography in Nonalcoholic Fatty Liver Disease.
    Radiology. 2024;312:e233094.
    PubMed     Abstract available
    
    
    
82. AHMED TM, Fishman EK
    Cinematic Rendering of Hepatic Hydatid Disease.
    Radiology. 2024;312:e240527.
    PubMed    
    
    
    
83. WILDMAN-TOBRINER B
    Photon-counting Detector CT: A Promising Tool for Noninvasive Liver Fat Assessment.
    Radiology. 2024;312:e241963.
    PubMed    
    
    
    
84. LIN H, Xu X, Deng R, Xu Z, et al
    Photon-counting Detector CT for Liver Fat Quantification: Validation across Protocols in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e240038.
    PubMed     Abstract available
    
    
    August 2024
85. SUGIMOTO K, Moriyasu F, Dioguardi Burgio M, Vilgrain V, et al
    US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD Study.
    Radiology. 2024;312:e233377.
    PubMed     Abstract available
    
    
    
86. YIN M
    Shear-Wave Dispersion for Detecting Hepatic Inflammation in Metabolic Dysfunction-associated Steatotic Liver Disease.
    Radiology. 2024;312:e241420.
    PubMed    
    
    
    
87. CHEUNG CL, Tripathi V, Chiang CL, Chiu KWH, et al
    Impact of Hepatocellular Carcinoma Etiology on the Performance of LI-RADS LR5.
    Radiology. 2024;312:e240056.
    PubMed    
    
    
    June 2024
88. KIM PH, Hwang JY, Choi YH, Yoon HM, et al
    Safety of Gadoxetate Disodium for Hepatobiliary MRI in Children and Adolescents.
    Radiology. 2024;311:e232462.
    PubMed     Abstract available
    
    
    
89. OTERO HJ
    Gadoxetate Disodium Hepatobiliary Contrast Material Is Safe in Children and Adolescents.
    Radiology. 2024;311:e241082.
    PubMed    
    
    
    May 2024
90. SARWAR A, Malik MS, Vo NH, Tsai LL, et al
    Efficacy and Safety of Radiation Segmentectomy with (90)Y Resin Microspheres for Hepatocellular Carcinoma.
    Radiology. 2024;311:e231386.
    PubMed     Abstract available
    
    
    
91. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    PubMed     Abstract available
    
    
    
92. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    PubMed     Abstract available
    
    
    
93. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.
    PubMed    
    
    
    
94. MILOT L
    Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e240124.
    PubMed    
    
    
    
95. LYSHCHIK A, Fetzer DT, Kono Y, Wilson SR, et al
    Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e232369.
    PubMed     Abstract available
    
    
    April 2024
96. YOON JH, Kim YK, Kim JW, Chang W, et al
    Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.
    Radiology. 2024;311:e233114.
    PubMed     Abstract available
    
    
    
97. LEE Y, Kim NH, Kang JH, Cho YS, et al
    Validation of Diagnostic Thresholds for Compensated Advanced Chronic Liver Disease Using Supersonic Shear Imaging.
    Radiology. 2024;311:e232188.
    PubMed     Abstract available
    
    
    
98. LYU L, Xu P
    Hepatic CT Perfusion in Budd-Chiari Syndrome before and after Intervention.
    Radiology. 2024;311:e232426.
    PubMed    
    
    
    
99. GHOSH A
    B-mode US and Deep Learning Rivals Shear-Wave Elastography in Screening for Fibrosis.
    Radiology. 2024;311:e240868.
    PubMed    
    
    
    
100. ZENG QQ, Liang P
     Super-Resolution US Imaging of Focal Nodular Hyperplasia.
     Radiology. 2024;311:e233130.
     PubMed    
     
     
     
101. CHEN LD, Huang ZR, Yang H, Cheng MQ, et al
     US-based Sequential Algorithm Integrating an AI Model for Advanced Liver Fibrosis Screening.
     Radiology. 2024;311:e231461.
     PubMed     Abstract available
     
     
     March 2024
102. MOURA CUNHA G, Fan B, Navin PJ, Olivie D, et al
     Interpretation, Reporting, and Clinical Applications of Liver MR Elastography.
     Radiology. 2024;310:e231220.
     PubMed     Abstract available
     
     
     
103. LIU F, Bi M, Jing X, Ding H, et al
     Multiparametric US for Identifying Metabolic Dysfunction-associated Steatohepatitis: A Prospective Multicenter Study.
     Radiology. 2024;310:e232416.
     PubMed     Abstract available
     
     
     
104. REUTER KL
     Noninvasive Identification of Metabolic Dysfunction-associated Steatohepatitis Globally.
     Radiology. 2024;310:e240436.
     PubMed    
     
     
     February 2024
105. CHAPIRO J
     Image-guided High-Dose-Rate Brachytherapy for Hepatocellular Carcinoma Could Be the Ultimate Ablation Tool.
     Radiology. 2024;310:e240072.
     PubMed    
     
     
     
106. AUER TA, Muller L, Schulze D, Anhamm M, et al
     CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
     Radiology. 2024;310:e232044.
     PubMed     Abstract available
     
     
     
107. SHEWAREGA A, Santana JG, Nam D, Berz A, et al
     Effect of Incomplete Cryoablation and Matrix Metalloproteinase Inhibition on Intratumoral CD8(+) T-Cell Infiltration in Murine Hepatocellular Carcinoma.
     Radiology. 2024;310:e232365.
     PubMed     Abstract available
     
     
     
108. GEMMETE JJ
     Partial Cryoablation and Matrix Metalloproteinase Inhibition May Be a Possible Treatment Option for Hepatocellular Carcinoma.
     Radiology. 2024;310:e240015.
     PubMed    
     
     
     
109. CRIVELLARO P
     A Deeper Look into Ancillary Features in LI-RADS Classification.
     Radiology. 2024;310:e240251.
     PubMed    
     
     
     
110. DAWIT H, Lam E, McInnes MDF, van der Pol CB, et al
     LI-RADS CT and MRI Ancillary Feature Association with Hepatocellular Carcinoma and Malignancy: An Individual Participant Data Meta-Analysis.
     Radiology. 2024;310:e231501.
     PubMed     Abstract available
     
     
     
111. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
     Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
     Radiology. 2024;310:e231160.
     PubMed     Abstract available
     
     
     
112. KARTALIS N, Grigoriadis A
     LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
     Radiology. 2024;310:e240161.
     PubMed    
     
     
     January 2024
113. MA L, Zhang W, Ma J, Luo J, et al
     Transjugular Intrahepatic Portosystemic Shunt versus Endoscopy with Drug Therapy Warrants Further Exploration.
     Radiology. 2024;310:e232499.
     PubMed    
     
     
     
114. TAN XZ, Chen X, Liu P
     Potential Influence of Inconsistent Arterial Phase Imaging on Macrotrabecular-massive Hepatocellular Carcinoma Prediction.
     Radiology. 2024;310:e232349.
     PubMed    
     
     
     
115. KADI D, Loomba R, Bashir MR
     Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions.
     Radiology. 2024;310:e222695.
     PubMed     Abstract available
     
     
     
116. FOWLER KJ, Chernyak V
     What Is in a Name: Understanding the Nomenclature Updates for Fatty Liver Disease.
     Radiology. 2024;310:e232771.
     PubMed    
     
     
     
117. DIETRICH CF
     Modified Algorithm for Contrast-enhanced US LI-RADS.
     Radiology. 2024;310:e232742.
     PubMed    
     
     
     December 2023
118. GOINS SM, Jiang H, van der Pol CB, Salameh JP, et al
     Individual Participant Data Meta-Analysis of LR-5 in LI-RADS Version 2018 versus Revised LI-RADS for Hepatocellular Carcinoma Diagnosis.
     Radiology. 2023;309:e231656.
     PubMed     Abstract available
     
     
     
119. SIRLIN CB, Chernyak V
     Are We Ready to Simplify and Improve LI-RADS?
     Radiology. 2023;309:e233164.
     PubMed    
     
     
     
120. TAMIR S, Tau N
     Hepatocellular Carcinoma and Pretransplant Liver Imaging: Benefits of Per-patient Assessment.
     Radiology. 2023;309:e233123.
     PubMed    
     
     
     
121. HASSAN OT, Behr SC, Ohliger MA, Fowler KJ, et al
     Per-patient Negative Predictive Value of the CT and MRI Liver Imaging Reporting and Data System Version 2018 Treatment Response Algorithm for Hepatocellular Carcinoma.
     Radiology. 2023;309:e222776.
     PubMed     Abstract available
     
     
     November 2023
122. JIANG H, Yang C, Chen Y, Wang Y, et al
     Development of a Model including MRI Features for Predicting Advanced-stage Recurrence of Hepatocellular Carcinoma after Liver Resection.
     Radiology. 2023;309:e230527.
     PubMed     Abstract available
     
     
     
123. HSIEH C, Laguna A, Ikeda I, Maxwell AWP, et al
     Using Machine Learning to Predict Response to Image-guided Therapies for Hepatocellular Carcinoma.
     Radiology. 2023;309:e222891.
     PubMed     Abstract available
     
     
     
124. TSAI R, Mellnick VM
     Using an Imaging Model to Predict Recurrence in Patients with Hepatocellular Carcinoma.
     Radiology. 2023;309:e232480.
     PubMed    
     
     
     
125. OZTURK A, Kumar V, Pierce TT, Li Q, et al
     The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease.
     Radiology. 2023;309:e223146.
     PubMed     Abstract available
     
     
     
126. TAN XZ, Liu P, Xiang H
     The Influence of Single Arterial Phase Imaging on Prediction of Microvascular Invasion of Hepatocellular Carcinoma.
     Radiology. 2023;309:e231141.
     PubMed    
     
     
     October 2023
127. TUTHILL TA
     Advancing AI-assisted US Screening for Fatty Liver.
     Radiology. 2023;309:e232442.
     PubMed    
     
     
     
128. HAN A
     Hepatic Steatosis Assessment: Harnessing the Power of Integrating Multiple Quantitative US Parameters.
     Radiology. 2023;309:e232475.
     PubMed    
     
     
     
129. VIANNA P, Calce SI, Boustros P, Larocque-Rigney C, et al
     Comparison of Radiologists and Deep Learning for US Grading of Hepatic Steatosis.
     Radiology. 2023;309:e230659.
     PubMed     Abstract available
     
     
     
130. KURODA H, Oguri T, Kamiyama N, Toyoda H, et al
     Multivariable Quantitative US Parameters for Assessing Hepatic Steatosis.
     Radiology. 2023;309:e230341.
     PubMed     Abstract available
     
     
     
131. SAVSANI E, Shaw CM, Forsberg F, Wessner CE, et al
     Contrast-enhanced US Evaluation of Hepatocellular Carcinoma Response to Chemoembolization: A Prospective Multicenter Trial.
     Radiology. 2023;309:e230727.
     PubMed     Abstract available
     
     
     
132. HEO S, Lee SS, Choi SH, Kim DW, et al
     CT Rule-in and Rule-out Criteria for Clinically Significant Portal Hypertension in Chronic Liver Disease.
     Radiology. 2023;309:e231208.
     PubMed     Abstract available
     
     
     
133. FRAUM TJ
     CT-based Diagnosis of Clinically Significant Portal Hypertension: An Opportunity to Prevent Complications.
     Radiology. 2023;309:e232439.
     PubMed    
     
     
     
134. XIA T, Du M, Li H, Wang Y, et al
     Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk.
     Radiology. 2023;309:e231007.
     PubMed     Abstract available
     
     
     
135. REEDER SB, Starekova J
     MRI Proton Density Fat Fraction for Liver Disease Risk Assessment: A Call for Clinical Implementation.
     Radiology. 2023;309:e232552.
     PubMed    
     
     
     
136. MONSELL SE
     Statistical Methods for Exploring Causal Relationships between Risk Factors and Liver Disease.
     Radiology. 2023;309:e232551.
     PubMed    
     
     
     
137. FOWLER KJ, Venkatesh SK, Obuchowski N, Middleton MS, et al
     Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE Consortium.
     Radiology. 2023;309:e231092.
     PubMed     Abstract available
     
     
     
138. KOZAKA K, Matsui O
     MRI Biomarkers and Their Future Impact on Nonalcoholic Fatty Liver Disease.
     Radiology. 2023;309:e232420.
     PubMed    
     
     
     September 2023
139. HYODO R, Takehara Y, Mizuno T, Ichikawa K, et al
     Four-dimensional Flow MRI Assessment of Portal Hemodynamics and Hepatic Regeneration after Portal Vein Embolization.
     Radiology. 2023;308:e230709.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum